Search

everythinglearnresearchcommunity

for

Search:↓

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

Iron infusions can help improve hair loss in patients who can't take oral iron supplements.

The treatment is safe and shows promise for metastatic breast cancer.

Tamsulosin hydrochloride is safe and effective for long-term treatment of urinary symptoms in BPH patients.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

The drug combination was safe and showed promise in treating advanced tumors.

5% minoxidil foam is a safe, effective treatment for male pattern hair loss, with increased hair count and few side effects.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

The domestic hair follicle extraction system is as effective and safe as traditional FUE.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Alcohol-free minoxidil 5% is effective and safe for treating male pattern hair loss.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

CTP-543 is generally safe for treating alopecia areata.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.